Molecule That Fights Oxidative Stress Could Lead to Alzheimer’s Therapy

Molecule That Fights Oxidative Stress Could Lead to Alzheimer’s Therapy
A new molecule capable of fighting oxidative stress, with high potential to be developed into a drug in pill form, has been identified by researchers at the University of Missouri (MU). This discovery could be a major step in fighting cancer, Alzheimer's, and Parkinson's disease. Mark Hannink is a professor in the Department of Biochemistry and a researcher at the Bond Life Sciences Center at MU. Along with Kim Jasmer, a graduate student in his lab, and North Carolina firm High Point Pharmaceuticals LLC, Hannink identified a compound known as HPP-4382, which was shown to be effective against oxidative stress. In order for cells to create energy, they "breathe" oxygen (received by the food we eat and the air we breathe), and by doing so, reactive molecules are created as a result of the breathing process. These residual molecules are the free radicals
Subscribe or to access all post and page content.